Specifically, whereas myosin light chain kinase (MYLK) and MYLK2 are down‐regulated by ~6‐fold in DMD cardiomyocytes, myosin light chain 2 (MYL2) is up‐regulated by 2‐fold. This evidence concerns the gene MYL2 and Duchenne muscular dystrophy.